Two Pharma Giants Quietly Pause Trials Of Promising New Autoimmune Therapies. Here’s Why
Novartis and Bristol Myers had been testing faster CAR-T approaches for diseases such as lupus and rheumatoid arthritis when serious safety concerns emerged.
See all — News18 →Aggregated from the leading newsrooms of the country. Every story links to its original source.







